TY  - GEN
AU  - Zhou,Wen-jing
AU  - Zhang,Xu
AU  - Cheng,Chao
AU  - Wang,Fang
AU  - Wang,Xiao-kun
AU  - Liang,Yong-ju
AU  - To,Kenneth Kin Wah
AU  - Zhou,Wang
AU  - Huang,Hong-bing
AU  - Fu,Li-wu
TI  - Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein
SN  - 1476-5381
PY  - 2012///1030
KW  - ATP Binding Cassette Transporter, Subfamily B, Member 1
KW  - antagonists & inhibitors
KW  - Adenosine Triphosphatases
KW  - metabolism
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Cell Line, Tumor
KW  - Crizotinib
KW  - Doxorubicin
KW  - pharmacokinetics
KW  - Drug Resistance, Multiple
KW  - drug effects
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Mice
KW  - Mice, Nude
KW  - Neoplasms
KW  - drug therapy
KW  - Paclitaxel
KW  - therapeutic use
KW  - Protein Kinase Inhibitors
KW  - Pyrazoles
KW  - Pyridines
KW  - Rhodamine 123
KW  - Tumor Burden
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1476-5381.2012.01849.x
ER  -